ASFH Fungal Keratitis in Endothelial Keratoplasty
Guest: Edmund Tsui, MD Department of Ophthalmology New York University School of Medicine New York, NY (Source: As Seen From Here)
Source: As Seen From Here - February 1, 2016 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
ASFH Managing Keratoconus without Keratoplasty at ESCRS
Guests: Jorge Alio, MD
Professor and Chairman of Ophthalmology
University of Alicante
University Miguel Hernandez de Elche
John Kanellopoulos, MD
Professor of Ophthalmology
NYU School of Medicine
New York, NY
Director, Laservision Institute
Athens, Greece (Source: As Seen From Here)
Source: As Seen From Here - June 20, 2015 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
ASFH: Limbal Stem Cell Grafts
Paper Discussed: Santos M, Gomes J, Hofling-Lima A, et al. Survival Analysis of Conjunctival Limbal Grafts and Amniotic Membrane Transplantation in Eyes With Total Limbal Stem Cell Deficiency American Journal of Ophthalmology, August 2005, 140(2) p223.e1-223.e10 Guest: Myrna SerapiÃo dos Santos, M.D. Specialist in External Ocular Diseases and Cornea Vision Institute of the Federal University of SÃo Paulo-Brazil Researcher at the Advanced Center of Ocular Surface Vision Institute-Federal Post-Doctoral Fellow at the Cornea Sector University of Rome Campus Bio-Medico Rome, Italy (Source: As Seen From Here)
Source: As Seen From Here - May 21, 2010 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
ISCO and Absorption Sytems to Commercialize Stem Cell Derived Human Corneal Tissue for Drug Test
International Stem Cell Corporation (OTCBB:ISCO (www.internationalstemcell.com), the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, has formed a partnership with Absorption Systems to utilize ISCO’s parthenogenetic stem cell-derived human corneal tissue to measure drug disposition, drug safety and drug-drug interactions. The collaboration between the companies is focused on using Absorption Systems’ know how in creating in vitro assay systems to develop a superior method of testing drugs that will also reduce the use of laborato...
Source: International Stem Cell Corporation - November 25, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine parthenogenesis stem cell Source Type: podcasts
ISCO and Absorption Sytems to Commercialize Stem Cell Derived Human Corneal Tissue for Drug Test
International Stem Cell Corporation (OTCBB:ISCO (www.internationalstemcell.com), the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, has formed a partnership with Absorption Systems to utilize ISCO’s parthenogenetic stem cell-derived human corneal tissue to measure drug disposition, drug safety and drug-drug interactions. The collaboration between the companies is focused on using Absorption Systems’ know how in creating in vitro assay systems to develop a superior method of testing drugs that will also reduce the use of laboratory animals curren...
Source: International Stem Cell Corporation - November 25, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine parthenogenesis stem cell Source Type: podcasts
ISCO and Absorption Sytems to Commercialize Stem Cell Derived Human Corneal Tissue for Drug Test
International Stem Cell Corporation (OTCBB:ISCO (www.internationalstemcell.com), the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, has formed a partnership with Absorption Systems to utilize ISCO’s parthenogenetic stem cell-derived human corneal tissue to measure drug disposition, drug safety and drug-drug interactions. The collaboration between the companies is focused on using Absorption Systems’ know how in creating in vitro assay systems to develop a superior method of testing drugs that will also reduce the use of laborato...
Source: International Stem Cell Corporation - November 25, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine parthenogenesis stem cell Source Type: podcasts
ASFH Deep Lamellar Endothelial Keratoplasty (DLEK)
Paper Discussed: Rajesh Fogla and Prema PadmanabhanInitial Results of Small Incision Deep Lamellar Endothelial Keratoplasty (DLEK).American Journal of Ophthalmology, 2006 February; 141: 346–351Guest: Rajesh Fogla DNB, FRCS (Ed), MMed (Ophth) Senior Consultant, Eye SurgeonCornea & Laser Refractive Surgeon Apollo Hospitals Hyderabad, India (Source: As Seen From Here)
Source: As Seen From Here - May 8, 2006 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
ASFH: The Big Bubble Technique
Paper Discussed: Rajesh Fogla and Prema Padmanabhan
Results of Deep Lamellar Keratoplasty Using the Big-bubble Technique in Patients With Keratoconus
American Journal of Ophthalmology, 2006 February; 141: 254-259
Guest: Rajesh Fogla DNB, FRCS (Ed), MMed (Ophth)
Senior Consultant, Eye Surgeon
Cornea & Laser Refractive Surgeon
Apollo Hospitals
Hyderabad, India (Source: As Seen From Here)
Source: As Seen From Here - March 19, 2006 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
ASFH: Conductive Keratoplasty after LASIK
Paper Discussed: Hersh PS, Fry KL, Chandrashekhar R, Fikaris DS.
Conductive keratoplasty to treat complications of LASIK and photorefractive keratectomy.
Ophthalmology, November 2005;112(11):1941-7
Guest: Peter S. Hersh, MD
Director, Cornea and Refractive Surgery
Clinical Professor of Ophthalmology
Institute of Ophthalmology and Visual Science
UMDNJ-New Jersey Medical School
Newark, New Jersey (Source: As Seen From Here)
Source: As Seen From Here - December 18, 2005 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
ASFH: Keratoconus and Risk
Paper Discussed: Reeves SW, Stinnett S, Adelman RA, et al.
Risk factors for progression to penetrating keratoplasty in patients with keratoconus.
American Journal of Ophthalmology, Oct 2005, 140(4) p607-11
Guest: Natalie Afshari, M.D.
Assistant Professor of Ophthalmology
Duke University Eye Center
Durham, North Carolina (Source: As Seen From Here)
Source: As Seen From Here - November 13, 2005 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
